NCT05217030: AAT/TBI

Efficacy of Animal Assisted Therapy in the Treatment of Patients With Traumatic Brain Injury

Completed NA Last updated 22 February 2022

What this trial tests

NA trial testing Animal assisted therapy in Traumatic Brain Injury in 70 participants. Completed in 31 December 2019.

Timeline

30 June 2014

Primary endpoint
30 November 2019

31 December 2019

Quick facts

Lead sponsor	Inova Health Care Services
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	70
Start date	30 June 2014
Primary completion	30 November 2019
Estimated completion	31 December 2019
Sites	1 location across United States

Drugs / interventions tested

• Animal assisted therapy

Conditions studied

• Traumatic Brain Injury — all drugs for Traumatic Brain Injury →

Sponsor

Inova Health Care Services — full company profile →

Who can join

Adults 18 to 89, any sex, with Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients admitted to the ED with moderate to severe traumatic brain injury defined by GCS less than or equal to 10 and confirmed by head CT scan or MRI were randomized into 2 groups: one receiving animal assisted therapy (AAT) and one not receiving animal assisted therapy. Efficacy of AAT was measured by patient's progression in the Glasgow Coma Scale (GCS), Rancho Los Amigos Scale (RLAS), and ability to follow multi-step commands (LoCmds).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.